{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T11:54:54Z","timestamp":1777204494414,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00415-017-8651-4","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T09:28:44Z","timestamp":1509701324000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China"],"prefix":"10.1007","volume":"265","author":[{"given":"Guixian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghuai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"issue":"1\u20132","key":"8651_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2014.12.031","volume":"349","author":"JT Peng","year":"2015","unstructured":"Peng JT, Cong HR, Yan R, Kong XY, Jiang HQ, Wei WB, Zhang XJ (2015) Neurological outcome and predictive factors of idiopathic optic neuritis in China. J Neurol Sci 349(1\u20132):94\u201398","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"8651_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2011.03.021","volume":"305","author":"C Lai","year":"2011","unstructured":"Lai C, Tian G, Liu W, Wei W, Takahashi T, Zhang X (2011) Clinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in China. J Neurol Sci 305(1\u20132):38\u201340","journal-title":"J Neurol Sci"},{"key":"8651_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-017-0491-9","author":"BN Choy","year":"2017","unstructured":"Choy BN, Ng AL, Lai JS (2017) Clinical characteristics of optic neuritis in Hong Kong population: 10-year review. Int Ophthalmol. doi:\n                        10.1007\/s10792-017-0491-9\n                        \n                     (Epub ahead of print)","journal-title":"Int Ophthalmol"},{"issue":"7","key":"8651_CR4","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-016-8155-7","volume":"263","author":"H Zhou","year":"2016","unstructured":"Zhou H, Zhao S, Yin D, Chen X, Xu Q, Chen T, Li X, Wang J, Li H, Peng C, Lin D, Wei S (2016) Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages. J Neurol 263(7):1382\u20131389","journal-title":"J Neurol"},{"issue":"8","key":"8651_CR5","first-page":"62","volume":"28","author":"Y Long","year":"2017","unstructured":"Long Y, Liang J, Wu L, Lin S, Gao C, Chen X, Qiu W, Yang Y, Zheng X, Yang N, Gao M, Chen Y, Wang Z, Su Q (2017) Different phenotypes at onset in neuromyelitis optica spectrum disorder patients with aquaporin-4 autoimmunity. Front Neurol 28(8):62","journal-title":"Front Neurol"},{"issue":"302","key":"8651_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2016.11.010","volume":"15","author":"J ZhangBao","year":"2017","unstructured":"ZhangBao J, Zhou L, Li X, Cai T, Lu J, Lu C, Zhao C, Quan C (2017) The clinical characteristics of AQP4 antibody positive NMO\/SD in a large cohort of Chinese Han patients. J Neuroimmunol 15(302):49\u201355","journal-title":"J Neuroimmunol"},{"issue":"4","key":"8651_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","volume":"15","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Dale RC, Brilot F (2016) Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev 15(4):307\u2013324","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8651_CR8","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","volume":"2","author":"SM Kim","year":"2015","unstructured":"Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, Lee KW, Waters P (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2(6):e163","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"8651_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, H\u00fcmmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M, In cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflamm 13(1):279","journal-title":"J Neuroinflamm"},{"issue":"1","key":"8651_CR10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, H\u00fcmmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M (2016) Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflamm 13(1):280","journal-title":"J Neuroinflamm"},{"issue":"7","key":"8651_CR11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","volume":"263","author":"M Sep\u00falveda","year":"2016","unstructured":"Sep\u00falveda M, Armangue T, Martinez-Hernandez E, Arrambide G, Sola-Valls N, Sabater L, T\u00e9llez N, Midaglia L, Ari\u00f1o H, Peschl P, Reindl M, Rovira A, Montalban X, Blanco Y, Dalmau J, Graus F, Saiz A (2016) Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol 263(7):1349\u20131360","journal-title":"J Neurol"},{"key":"8651_CR12","doi-asserted-by":"crossref","first-page":"197140091769885","DOI":"10.1177\/1971400917698856","volume":"1","author":"C Michaela","year":"2017","unstructured":"Michaela C, Vincenza F, Matteo C, Marta P, Giancarlo O (2017) Anti-myelin oligodendrocyte glycoprotein antibodies: magnetic resonance imaging findings in a case series and a literature review. Neuroradiol J 1:1971400917698856","journal-title":"Neuroradiol J"},{"issue":"305","key":"8651_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2017.01.007","volume":"15","author":"L Zhou","year":"2017","unstructured":"Zhou L, Huang Y, Li H, Fan J, Zhangbao J, Yu H, Li Y, Lu J, Zhao C, Lu C, Wang M, Quan C (2017) MOG-antibody associated demyelinating disease of the CNS: a clinical and pathological study in Chinese Han patients. J Neuroimmunol 15(305):19\u201328","journal-title":"J Neuroimmunol"},{"issue":"3","key":"8651_CR14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, K\u00fcker W, Chandratre S, Vincent A, Palace J (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71(3):276\u2013283","journal-title":"JAMA Neurol"},{"issue":"1","key":"8651_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-016-8333-7","volume":"264","author":"J Havla","year":"2017","unstructured":"Havla J, K\u00fcmpfel T, Schinner R, Spadaro M, Schuh E, Meinl E, Hohlfeld R, Outteryck O (2017) Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. J Neurol 264(1):139\u2013151","journal-title":"J Neurol"},{"issue":"4","key":"8651_CR16","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","volume":"2","author":"K Chalmoukou","year":"2015","unstructured":"Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC (2015) Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm 2(4):e131","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"8651_CR17","doi-asserted-by":"crossref","first-page":"e007766","DOI":"10.1136\/bmjopen-2015-007766","volume":"5","author":"H Nakajima","year":"2015","unstructured":"Nakajima H, Motomura M, Tanaka K, Fujikawa A, Nakata R, Maeda Y, Shima T, Mukaino A, Yoshimura S, Miyazaki T, Shiraishi H, Kawakami A, Tsujino A (2015) Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ Open 5(4):e007766","journal-title":"BMJ Open"},{"issue":"4","key":"8651_CR18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","volume":"87","author":"T Akaishi","year":"2016","unstructured":"Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H, Kurosawa K, Kaneko K, Kuroda H, Nishiyama S, Misu T, Nakazawa T, Fujihara K, Aoki M (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin Oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 87(4):446\u2013448","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"8651_CR19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","volume":"23","author":"ED Pelt van","year":"2016","unstructured":"van Pelt ED, Wong YY, Ketelslegers IA, Hamann D, Hintzen RQ (2016) Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. Eur J Neurol 23(3):580\u2013587","journal-title":"Eur J Neurol"},{"issue":"9","key":"8651_CR20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326(9):581\u2013588","journal-title":"N Engl J Med"},{"issue":"2","key":"8651_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"8651_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jns.2015.08.1538","volume":"358","author":"S Zhao","year":"2015","unstructured":"Zhao S, Chen T, Peng C, Zhou H, Li H, Huang D, Xu Q, Wei S (2015) The putative acceleration of optic neuritis when combined with chronic hepatitis B. J Neurol Sci 358(1\u20132):207\u2013212","journal-title":"J Neurol Sci"},{"issue":"3","key":"8651_CR23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","volume":"30","author":"M Reindl","year":"2017","unstructured":"Reindl M, Jarius S, Rostasy K, Berger T (2017) Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they? Curr Opin Neurol 30(3):295\u2013301","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"8651_CR24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, H\u00fcmmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B, In cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement\u2014frequency, presentation and outcome. J Neuroinflamm 13(1):281","journal-title":"J Neuroinflamm"},{"issue":"1","key":"8651_CR25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","volume":"13","author":"F Pache","year":"2016","unstructured":"Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU, In cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflamm 13(1):282","journal-title":"J Neuroinflamm"},{"issue":"2","key":"8651_CR26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00415-015-7983-1","volume":"263","author":"L Piccolo","year":"2016","unstructured":"Piccolo L, Woodhall M, Tackley G, Jury\u0144czyk M, Kong Y, Domingos J, Gore R, Vincent A, Waters P, Leite MI, Palace J (2016) Isolated new onset \u2018atypical\u2019 optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. J Neurol 263(2):370\u2013379","journal-title":"J Neurol"},{"issue":"Pt 2","key":"8651_CR27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awr264","volume":"135","author":"SB Syc","year":"2012","unstructured":"Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, Crainiceanu CM, Durbin MK, Oakley JD, Meyer SA, Frohman EM, Calabresi PA (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 135(Pt 2):521\u2013533","journal-title":"Brain"},{"issue":"2","key":"8651_CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ophtha.2012.07.066","volume":"120","author":"DB Fernandes","year":"2013","unstructured":"Fernandes DB, Raza AS, Nogueira RG, Wang D, Callegaro D, Hood DC, Monteiro ML (2013) Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology 120(2):387\u2013394","journal-title":"Ophthalmology"},{"key":"8651_CR29","doi-asserted-by":"publisher","first-page":"832784","DOI":"10.1155\/2015\/832784","volume":"2015","author":"G Tian","year":"2015","unstructured":"Tian G, Li Z, Zhao G, Feng C, Li M, Huang Y, Sun X (2015) Evaluation of retinal nerve fiber layer and ganglion cell complex in patients with optic neuritis or neuromyelitis optica spectrum disorders using optical coherence tomography in a Chinese cohort. J Ophthalmol 2015:832784. doi:\n                        10.1155\/2015\/832784\n                        \n                     (Epub 2015 Nov 15)","journal-title":"J Ophthalmol"},{"issue":"7","key":"8651_CR30","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1167\/iovs.11-9324","volume":"53","author":"ML Monteiro","year":"2012","unstructured":"Monteiro ML, Fernandes DB, Ap\u00f3stolos-Pereira SL, Callegaro D (2012) Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography. Investig Ophthalmol Vis Sci 53(7):3959\u20133966","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"8651_CR31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"JN Ratchford","year":"2009","unstructured":"Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73(4):302\u2013308","journal-title":"Neurology"},{"issue":"12","key":"8651_CR32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","volume":"72","author":"RT Naismith","year":"2009","unstructured":"Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72(12):1077\u20131082","journal-title":"Neurology"},{"issue":"1","key":"8651_CR33","doi-asserted-by":"crossref","first-page":"e0170847","DOI":"10.1371\/journal.pone.0170847","volume":"12","author":"H Stiebel-Kalish","year":"2017","unstructured":"Stiebel-Kalish H, Lotan I, Brody J, Chodick G, Bialer O, Marignier R, Bach M, Hellmann MA (2017) Retinal nerve fiber layer may be better preserved in MOG-IgG versus AQP4-IgG optic neuritis: a cohort study. PLoS One 12(1):e0170847","journal-title":"PLoS One"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8651-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T09:58:18Z","timestamp":1515491898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8651-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["8651"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8651-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}